The transplacental transfer efficiency of per- and polyfluoroalkyl substances (PFAS): a first meta-analysis
Open accessThe DOI matches its Crossref record; 81 of the 84 references it cites were found in a registry or an index; 4 of the 48 sources its claims cite were checked for support.
Abstract
Per- and polyfluorinated substances (PFAS), ubiquitously present in the environment and biota, are transferred to the fetus via the placenta. PFAS can be distinguished, among other things, by their different carbon chain lengths and functional groups. The aim of this study was to provide comprehensive evidence on PFAS transfer rates across the human placental barrier by means of a meta-analysis based upon a systematic review. The available literature up to April 2021 was reviewed and transplacental transfer efficiencies (TTEs) of PFAS assessed. A total of 39 studies reporting data on 20 PFAS were included in the systematic review. Of these, 20 studies with data on 19 compounds were included in the meta-analysis. Comprehensive Meta-Analysis (CMA v3.0) was used for quantitative, statistical analyses with random effects models. A curvilinear relationship was found with short and long chains of perfluorocarboxylic acids (PFCAs) exhibiting higher TTE than compounds with intermediate chain length. Among the less well studied PFAS, perfluorohexanoic acid (PFHxA), 6:2 fluorotelomersulfonic acid (6:2 FTS) and perfluorobutanoic acid (PFBA) stood out the most with a high TEEs. The dependence of TTEs on chain length and functional group is clearly shown in this first meta-analysis on PFAS transfer across the human placenta. More data on effects of less well studied PFAS in pregnant women and neonates are needed to assess the potential risk for fetal exposure.
Overview
CoChat Summary
TL;DR
This first meta-analysis of PFAS transplacental transfer found that transfer efficiency depends on carbon chain length and functional group, with perfluorocarboxylic acids showing a U-shaped trend and carboxyl groups transferring more efficiently than sulfonyl groups. Less-studied PFAS such as PFHxA, 6:2 FTS, and PFBA showed high transfer efficiencies.
Key findings
- The systematic review included 39 studies reporting data on 20 PFAS; the meta-analysis included 20 studies with data on 19 compounds. PFOS and PFOA were the most frequently measured, found in 37 studies with 3,937 maternal and 3,793 cord serum samples.
- For PFCAs, random-effects TTEs showed a curvilinear/U-shaped relationship: PFHxA (C6) 2.19 ± 0.94, PFDA (C10) 0.32 ± 0.02, and PFTeDA (C14) 1.68 ± 0.17. PFBA (C4) had high variability and lower transfer than PFHxA.
- For PFSAs, TTEs decreased with chain length: PFHxS (C6) 0.59 ± 0.03, PFHpS (C7) 0.58 ± 0.12, and PFOS (C8) 0.44 ± 0.02. PFOA TTE was approximately 2-fold higher than PFOS (0.8 vs. 0.44), indicating functional group effects.
- Among “other PFAS,” 6:2 FTS had a TTE of 2.03 ± 0.51, PFOSA 0.84 ± 0.20, 6:2 Cl-PFESA 0.48 ± 0.03, 8:2 Cl-PFESA 0.71 ± 0.06, NMeFOSAA 0.94 ± 0.07, and NEtFOSAA 1.17 ± 0.10; no clear chain-length or functional-group trend was identified. Sampling time significantly affected PFOSA TTE (0.6 within two weeks of delivery vs. 1.27 at delivery), while year and region showed no marked effects.
Methods
- Systematic review followed PRISMA and PECO, registered in PROSPERO (CRD42020210003); Scopus and PubMed were searched up to April 2021. From 496 records plus 8 hand-searched records, 355 remained after duplicate removal, 43 full texts were screened, and 39 studies were included in the systematic review.
- Inclusion criteria were cross-sectional human studies reporting TTEs or data to calculate them, written in English; non-human studies and pooled blood samples were excluded. TTEs were calculated as cord blood concentration divided by maternal blood concentration when not reported.
- Meta-analysis used Comprehensive Meta-Analysis (CMA v3.0) with random effects models; mean values were the effect size, and medians/IQRs were converted using Luo et al. (2018). Q-statistics, I², prediction intervals, pairwise mixed-effects comparisons, and moderation analyses (sampling time, region, year) were performed; risk of bias was assessed with AXIS and rated low.
Limitations
- The paper states that insufficient data on PFSAs with chain length >C8 prevented assessment of a curvilinear relationship; some compounds had few studies (PFBA, PFHxA, PFHpA: 3–4 studies; PFBS: 2 studies and excluded from meta-analysis), and high variability/high standard deviations were striking for C4–C7 and C12–C14 compounds.
- The authors note that no developmental outcome studies were found for 6:2 FTS, and data on PFHxA and PFBA effects on fetal health are limited; year and region findings may be too early to generalize due to low study numbers, and future meta-analyses should address structural specificities and analytical methods.
- Evident from the text: only 20 of 39 systematic-review studies could be meta-analyzed due to missing descriptive statistics; outliers (e.g., Midasch et al. N=11; Li et al. high PFNA/PFTrDA; Cai et al. high TTEs with high SD) may influence estimates; detection limits and sampling timing may affect TTEs; no studies from South America or Australia met inclusion criteria.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 2 Not valid · 30 Not checked · 62 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Short- and long-chain compounds appear to be transported across the placental barrier more efficiently than medium-chain compounds.”
What the sources say
- Not matchedcites Cai et al. 2020
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites Eryasa et al. 2019 sourceExperimental — accuracy not yet measured
The Results (Predictors of transplacental transfer and partitioning ratios; page unavailable) report a U-shaped relationship for perfluorocarboxylates and perfluorosulfonates, consistent with greater transfer at shorter and longer chain lengths than at intermediate lengths. The claim is broader than that finding: the same section reports that transfer ratios for sulfonamide precursors decreased as chain length increased. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites Gao et al. 2019 source
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Per- and polyfluorinated substances (PFAS), ubiquitously present in the environment and biota, are transferred to the fetus via the placenta.”
- Also stated in: § Introduction · plain
“The main sources of human exposure are food, drinking water, dust and inhaled air (Fromme et al. Citation2009; Haug et al. Citation2011), transplacental transfer (Cai et al. Citation2020; Fisher et al. Citation2016; Wang et al. Citation2019), and breastfeeding (Loccisano et al. Citation2013).”
What the sources say
- Not matchedcites Cai et al. 2020
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites Fisher et al. 2016 sourceExperimental — accuracy not yet measured
Our copy of Fisher et al. (2016, MIREC) provides the fetal-side evidence underlying the claim: the Abstract Results/Discussion report PFAS (PFOA, PFOS, PFHxS) measured in matched 1st-trimester maternal and cord plasma, with PFAS the most frequently detected class in cord plasma (23–64 %), cord:maternal ratios as low as 0.14 (PFOS), and cord PFOA significantly correlated with maternal PFOA (p < 0.0001) — i.e. PFAS reach the fetal circulation. But the paper never states the mechanistic claim that PFAS 'are transferred to the fetus via the placenta'; it frames pregnancy as a route of 'developmental exposures of the fetus' (Background) and cites placental-transfer studies (Porpora et al. 2013, ref 8; Vizcaino et al. 2014, ref 9) for POPs generally. Likewise, the 'ubiquitously present in the environment and biota' descriptor is only partly matched — the Background says PFAS are highly persistent in the environment and widely used in products, not ubiquitous in biota. So the transfer-to-fetus observation is supported while the placental-mechanism assertion, the whole PFAS class (only three analytes were measured), and the ubiquity-in-biota framing are not. (LLM, conf=0.72)
- Not matchedcites Wang et al. 2019
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · plain
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Transplacental transfer efficiency (TTE) of PFAS seems to depend upon carbon chain length and functional groups (PFCAs and perfluorosulfonic acids (PFSAs)).”
What the sources say
- Not matchedcites Cai et al. 2020
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Supportedcites Eryasa et al. 2019 source
The Results section reports that PFAS transplacental transfer ratios differ by functional group, with lower ratios for PFSAs than PFCAs. It also reports an association with carbon chain length, including distinct chain-length patterns for PFCAs and PFSAs. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites Gao et al. 2019 source
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“PFHxA (C6) has a weighted TTE of 2.19 ± 0.94.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“PFHpS (C7) and PFOS (C8) presented calculated TTEs of 0.58 ± 0.12 and 0.44 ± 0.02, respectively.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
54 more claims
Create a free account to see all 98 claims and to verify the 6 references still open.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 19
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Given that the human placenta may be a primary target of PFAS exposure in pregnant women and PFASs can be transferred across the placenta, further research is needed to reveal the role of PFASs in placental function and maternal-infant health during pregnancy (Appel et al., 2022; Stern et al., 2021).”
From Exposure to per- and polyfluoroalkyl substances in early pregnancy, risk of gestational diabetes mellitus, potential pathways, and influencing factors in pregnant women: A nested case-control study (2023) · cites this paper as Appel et al., 2022
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Given that the human placenta may be a primary target of PFAS exposure in pregnant women and PFASs can be transferred across the placenta, further research is needed to reveal the role of PFASs in placental function and maternal-infant health during pregnancy (Appel et al., 2022; Stern et al., 2021).”
From Exposure to per- and polyfluoroalkyl substances in early pregnancy, risk of gestational diabetes mellitus, potential pathways, and influencing factors in pregnant women: A nested case-control study (2023) · cites this paper as Appel et al., 2022
Citations
Cites
A basic introduction to fixed-effect and random-effects models for meta-analysis
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2010) · Research Synthesis Methods · doi:10.1002/jrsm.12 · Cited by 6,793
Luo, D., Wan, X., Liu, J., & Tong, T. (2018) · Statistical Methods in Medical Research · doi:10.1177/0962280216669183 · Cited by 4,066
Sunderland, E. M., Hu, X. C., Dassuncao, C., Tokranov, A. K., Wagner, C. C., & Allen, J. G. (2019) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-018-0094-1 · Cited by 2,786 · cited 1×
“Per- and polyfluoroalkyl substances (PFAS) are of particular interest due to extensive dispersal, persistence in the environment, bioaccumulation, and adverse health effects exerted on wildlife and humans (Muller et al. 2011; Giesy and Kannan 2001; Sunderland et al. 2019; EFSA 2020).”
BackgroundGlobal Distribution of Perfluorooctane Sulfonate in Wildlife
Giesy, J. P., & Kannan, K. (2001) · Environmental Science & Technology · doi:10.1021/es001834k · Cited by 2,750 · cited 3×
“Biomonitoring studies demonstrated that PFAS accumulate in wildlife (Giesy and Kannan 2001) and humans throughout the world (Fromme et al. 2009; Lau et al. 2007; Xu et al. 2020).”
BackgroundPerfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620 · cited 1×
“Biomonitoring studies demonstrated that PFAS accumulate in wildlife (Giesy and Kannan 2001) and humans throughout the world (Fromme et al. 2009; Lau et al. 2007; Xu et al. 2020).”
BackgroundDevelopment of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)
Downes, M. J., Brennan, M. L., Williams, H. C., & Dean, R. S. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011458 · Cited by 2,376 · cited 2×
“To assess the risk of bias (RoB) and check the quality of the 39 studies included in the systematic review and the 20 investigations included in the metaanalysis, the appraisal tool for cross-sectional studies (AXIS) was used (Table S1) (Downes et al. 2016).”
MethodPlea for routinely presenting prediction intervals in meta-analysis.
IntHout, J., Ioannidis, J. P. A., Rovers, M. M., & Goeman, J. J. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010247 · Cited by 2,264 · cited 2×
“…Kim S-K et al. 2011 Beeson et al. 2011 PFDA (C10) 0.34±0.06 0.33±0.02 0.35±0.04 0.29±0.01 0.18±0.01 0.62±0.10 0.33±0.01 0.28±0.01 0.23±0.01 0.23±0.01 0.42±0.10 0.32±0.02 0.32±0.16 mean±SE a correction in the use and reporting of heterogeneity estimates (Borenstein et al. 2017; IntHout et al. 2016).”
BackgroundInfluentialOlsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., & Zobel, L. R. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10009 · Cited by 2,049 · cited 1×
“Biological half-lives in humans range from days, for compounds with a shorter chain length, to years for compounds with a longer perfluoroalkyl chain (Bartell et al. 2010; Chang et al. 2008; Olsen et al. 2007; Pizzurro et al. 2019; Xu et al. 2020).”
BackgroundBasics of meta‐analysis: I 2 is not an absolute measure of heterogeneity
Borenstein, M., Higgins, J. P. T., Hedges, L. V., & Rothstein, H. R. (2017) · Research Synthesis Methods · doi:10.1002/jrsm.1230 · Cited by 1,848
Morgan, R. L., Whaley, P., Thayer, K. A., & Schünemann, H. J. (2018) · Environment International · doi:10.1016/j.envint.2018.07.015 · Cited by 1,282 · cited 2×
“The PECO question for the systematic review was as follows: “Do chain length and functional group influence PFAS transfer efficiency from mother to child during pregnancy?””
Method
Research works printed but not linked: 2
- ATSDR. Agency for Toxic Substances and Disease Registry, 2021, Toxicological profile for perfluoroalkyls, chapter 2. Health effects
- Schrenk D., 2020, EFSA J., 18, e06223
Cited by
Toward a mechanistic understanding of poly-and perfluoroalkylated substances and cancer
Boyd, R. I., Ahmad, S., Singh, R., Fazal, Z., Prins, G. S., Madak Erdogan, Z., Irudayaraj, J., & Spinella, M. J. (2022) · Cancers · doi:10.3390/cancers14122919 · Cited by 110
“PFAS cross t concentrate in breast milk; thus, exposure to the d veloping fetus and i fant occurs [73,74].”
BackgroundDeterminants of maternal and neonatal PFAS concentrations: a review
McAdam, J., & Bell, E. M. (2023) · Environmental Health · doi:10.1186/s12940-023-00992-x · Cited by 91
“Potential health outcomes associated with short-chain PFAS and alternatives are still not well understood, though shortchain PFAS appear to cross the placental barrier at rates like long-chain PFAS and limited evidence has suggested deleterious effects following exposure [175, 176].”
BackgroundNeurotoxicity of per- and polyfluoroalkyl substances: Evidence and future directions
Bharal, B., Ruchitha, C., Kumar, P., Pandey, R., Rachamalla, M., Niyogi, S., Naidu, R., & Kaundal, R. K. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.176941 · Cited by 101
Zhou, Y., Li, Q., Wang, P., Li, J., Zhao, W., Zhang, L., Wang, H., Cheng, Y., Shi, H., Li, J., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.107850 · Cited by 79
Kavusi, E., Ansar, B. S. K., Ebrahimi, S., Sharma, R., Ghoreishi, S. S., Nobaharan, K., Abdoli, S., Dehghanian, Z., Lajayer, B. A., Senapathi, V., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114844 · Cited by 82
Metadata
- Authors
- Appel, M., Forsthuber, M., Ramos, R., Widhalm, R., Granitzer, S., Uhl, M., Hengstschläger, M., Stamm, T., & Gundacker, C.
- Affiliations
- Medical University of Vienna (AT)
- Karl Landsteiner University of Health Sciences (AT)
- Environment Agency Austria (AT)
- Corresponding author
- Forsthuber, Martin
- ORCID
- Venue
- Journal of Toxicology and Environmental Health, Part B
- Publisher
- Informa UK Limited
- Published
- 2021-12-20
- Volume
- 25
- Issue
- 1
- Pages
- 23-42
- ISSN
- 1093-7404 (ISSN-L)
- 1521-6950
- OpenAlex
- W4200163091
- Semantic Scholar
- 789e7e1124c99445500ddd9c6fecef943fe955b0
- Cited by
- 104
- References
- 81
- Citations by year
- 2026: 28 · 2025: 29 · 2024: 21 · 2023: 20 · 2022: 6
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Toxicology and Environmental Health Part B (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- did not receive any specific grant
- Topics
- Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Physical Sciences › Chemistry › Organic Chemistry › Fluorine in Organic Chemistry
- Keywords
- per- and polyfluoroalkyl substances, PFAS, placental barrier, perfluorocarboxylic acids, chain length, functional groups, perfluorohexanoic acid, perfluorobutanoic acid, prenatal exposure, pregnancy
- MeSH terms
- Caproates, Environmental Exposure, Environmental Pollutants, Female, Fluorocarbons, Humans, Infant, Newborn, Placenta, Pregnancy, Prenatal Exposure Delayed Effects
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The transplacental transfer efficiency of per- and polyfluoroalkyl substances (PFAS): a first meta-analysis. https://app.cochat.ai/papers/10.1080/10937404.2021.2009946
- The paper
- Appel, M., Forsthuber, M., Ramos, R., Widhalm, R., Granitzer, S., Uhl, M., Hengstschläger, M., Stamm, T., & Gundacker, C. (2022). The transplacental transfer efficiency of per- and polyfluoroalkyl substances (PFAS): a first meta-analysis. Journal of Toxicology and Environmental Health, Part B. https://doi.org/10.1080/10937404.2021.2009946
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.